Related Experiment Video
Updated: May 28, 2026

An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota
Published on: July 31, 2019
Caffeic Acid Release from Inulin Caffeate: A Comparative Study with Spray-Dried Inulin Microparticles Under
Patricio Romero-Hasler1, Alejandra Quintriqueo-Cid1, Begoña Giménez2
1Departamento de Ciencia de los Alimentos y Tecnología Química, Facultad de Ciencias Químicas y Farmacéuticas, Universidad de Chile, Dr. Carlos Lorca Tobar 964, Independencia, Santiago 81380494, Chile.
Covalently binding caffeic acid (CA) to inulin offers targeted delivery in the gut, unlike spray-dried microparticles which release CA rapidly. This method enhances phenolic compound bioavailability.
Area of Science:
- Food Science & Technology
- Biomaterials Engineering
- Pharmacology
Background:
- Phenolic compounds, like caffeic acid (CA), possess antioxidant properties but often exhibit poor bioavailability.
- Inulin, a prebiotic fiber, can be modified to improve the delivery of bioactive compounds.
- Developing strategies for controlled release of phenolic compounds in the gastrointestinal tract is crucial for enhancing their health benefits.
Purpose of the Study:
- To compare the physicochemical properties and in vitro gastrointestinal release profiles of covalently bound caffeic acid-inulin (CA-Inu) with spray-dried CA-inulin microparticles (Mp(CA/Inu)).
- To evaluate the potential of covalent conjugation for targeted delivery of phenolic compounds.
Main Methods:
- Synthesis of inulin caffeate (CA-Inu) with a degree of substitution of 0.07.
- Optimization of spray-drying encapsulation of CA with inulin (Mp(CA/Inu)) using Central Composite Design.
- In vitro simulated gastrointestinal digestion to assess CA release from both formulations.
Main Results:
- Spray-dried microparticles (Mp(CA/Inu)) showed rapid CA release during oral and gastric phases, with a slight decrease in the intestinal phase.
- Covalently bound inulin caffeate (CA-Inu) exhibited no CA release in oral and gastric phases.
- Approximately 30% CA release occurred in the intestinal phase from CA-Inu, increasing in the colonic phase, particularly with inulinase.
Conclusions:
- Covalent binding of CA to inulin provides a robust strategy for delaying the release of phenolic compounds.
- This approach enables targeted delivery of bioactive compounds to the later stages of gastrointestinal digestion.
- The developed CA-Inu conjugate shows potential for enhanced delivery and efficacy of phenolic compounds.
More Related Videos
07:42Green Synthesis, Characterization, Encapsulation, and Measurement of the Release Potential of Novel Alkali Lignin Micro-/Submicron Particles
Published on: March 1, 2024
14:39Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults
Published on: April 22, 2022
Related Concept Videos
Modified-Release Drug Delivery Systems: Bioavailability
Methods for Studying Drug Absorption: In vitro
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...
Methods for Studying Drug Absorption: In situ
The Doluisio method involves perfusing a prepared segment of a rat's small intestine with a solution of radiolabeled drug and a non-absorbable marker. This helps to differentiate between absorbed and non-absorbed drug concentrations. The intestinal segment is connected at both ends using tubing and syringes,...
Carbohydrate Digestion